Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial
Abstract Purpose This multicenter Phase II clinical study assessed the efficacy and safety of hypofractionated radiotherapy (HFRT) in combination with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor (GM-CSF), and thymosin-α1 in patients with heavily treated metastatic solid tumors...
Saved in:
Main Authors: | Jiamin Yu, Li Yin, Wenjie Guo, Qiang Wang, Juying Liu, Lansheng Zhang, Hongxun Ye, Jianhong Xia, Youyou Xia, Jianfeng Wu, Wanwei Wang, Yanguang Yang, Dan Zong, Xia He, Lijun Wang, Hong Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-02-01
|
Series: | Cancer Immunology, Immunotherapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00262-024-03934-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
by: Paweł J. Polanowski, et al.
Published: (2024-09-01) -
AKT1-Mediated NOTCH1 phosphorylation promotes gastric cancer progression via targeted regulation of IRS-1 transcription
by: Lingshan Zhou, et al.
Published: (2024-12-01) -
HACE1 protects against myocardial ischemia–reperfusion injury via inhibition of mitochondrial fission in mice
by: Bang-Xia Liu, et al.
Published: (2025-02-01) -
Translational regulation of PKD1 by evolutionarily conserved upstream open reading frames
by: Lei Chen, et al.
Published: (2025-12-01) -
Faith, hope and love - a missionary perspective on three seminal motifs in 1 Thessalonians 1:3
by: P. G. R. de Villiers
Published: (2003-06-01)